| Literature DB >> 21969844 |
Rupesh Raina1, James F Simon, Chad R Marion, Arrossi Valeria, Sankar D Navaneethan, Gustavo A Heresi, Jorge A Guzman, Edgard Wehbe, Joseph V Nally.
Abstract
Entities:
Year: 2011 PMID: 21969844 PMCID: PMC3182259 DOI: 10.1093/ndtplus/sfr076
Source DB: PubMed Journal: NDT Plus ISSN: 1753-0784
Fig. 1.(A) Magnification (×25) of lung tissue demonstrating histiocytic infiltration of the subpleural and intralobar septa. (B) Magnification (×40) of lung tissue from the boxed area in Figure 1A. This demonstrates histiocytic proliferation with fibrosis in a subpleural and bronchovascular bundle distribution indicated by >. (C) Magnification (×20) of lung tissue histiocyte staining for CD68 (brown area) in Figure Ca and but CD1a negative in Figure Cb. (D) Magnification (×10) of renal tissue demonstrating interstitial fibrosis and chronic inflammation marked by > that stained negative for CD1a (not shown).
Fig. 2.XR tibia fibula AP/LAT. The tibias show abnormal sclerosis in the distal two-thirds with sparing of the epiphyses. There is some irregular lucency. Cortical thickening is present with resultant narrowing of the medullary canals indicated by >. Similar findings are present in each fibula predominantly distally as well as both femurs.
Fig. 3.Whole body FDG-PET demonstrates diffuse increased vascular markings in the lung, pleural, adrenals and kidneys consistent with inflammatory or infectious process. (A) **Illustrates a representative area of aortic FDG uptake. (B) >Indicates a representative area of renal FDG uptake.
Classification of histiocytic disorders
| Class I: Langerhans cell histiocytosis |
| x2003;x2003;Eosinophilic granuloma, Hand-Schuller-Christian disease, Letterer-Siwe disease (Abt Letterer Siwe disease) |
| Class II: NLH |
| x2003;x2003;Hemophagocytic lymphohistiocytosis (familial erythrophagocytic lymphohistiocytosis), virus-associated hemophagocytic syndrome, sinus histiocytosis with massive lymphadenopathy (Rosai–Dorfman disease), ECD, xanthogranuloma, xanthoma disseminatium, reticulohistiocytoma, juvenile xanthogranulomatosis |
| Class III: malignant histiocytic disorders |
| x2003;x2003;Acute monocytic leukemia, malignant histiocytosis, histiocytic lymphoma |
(Adapted from 1, 2).
Langerhans versus non-Langerhans cell histiocytoses
| Variables | Langerhans cell | Non-Langerhans cell |
| Age | Children and juveniles | |
| Histopathology | Bone-marrow derived antigen presenting cells not of monocyte-macrophage lineage | Infiltration of multiple organ sites by foamy histiocytes, lymphocytes and scattered Touton giant cells with extensive fibrosis |
| Immunohistochemical staining | CD1a+, S-100+, CD68− | CD1a−, S-100 essentially negative, CD68+ |
| Clinical manifestations | Irregular lytic lesions in the medulla, usually with endosteal erosion usually sparing hands and feet | Symmetric, sclerotic lesions of long bones |
| Proptosis, rare vision loss | Dyspnea and respiratory failure due to interstitial lung disease | |
| Destruction of ossicles and deafness and mastoid pain | Hydronephrosis and renal failure secondary to retroperitoneal xanthogranulomatosis | |
| Seborrhea-like skin papules on back, palms, and sole | Diabetes insipidus | |
| Hepatic dysfunction | Extra-axial masses (dural nodules) | |
| Cough, tachypnea, pneumothorax with pulmonary involvement | Retro-orbital masses with visual disturbances | |
| Hyperprolactinemia and hypogonadism from hypothalamic infiltration | Ataxia secondary to cerebellar involvement | |
| Pericardial infiltration may lead to pericardial effusion |
(Adapted from 1–3).